During the past decade, Unità Operativa Ematologia e Centro Trapianti - Dipartimento di Oncologia ed Ematologia - AUSL Ospedale di Piacenza conducted 31 clinical trials. In the 10-year time frame, 31 clinical trials started and 5 clinical trials were completed, i.e. on average, 16.1% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 3 clinical trials were completed. i.e. 27.3% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Unità Operativa Ematologia e Centro Trapianti - Dipartimento di Oncologia ed Ematologia - AUSL Ospedale di Piacenza" #1 collaborator was "CML Advocates Network" with 1 trials as a collaborator, "ERIC Group" with 1 trials as a collaborator, "European Leukemia Net" with 1 trials as a collaborator, "European Organisation for Research and Treatment of Cancer - EORTC" with 1 trials as a collaborator and "Hematology Project Foundation" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Unità Operativa Ematologia e Centro Trapianti - Dipartimento di Oncologia ed Ematologia - AUSL Ospedale di Piacenza" are "Chronic Myeloid Leukemia" (9 trials), "Chronic Lymphocytic Leukemia" (5 trials), "Acute Myeloid Leukemia" (4 trials), "Adult" (2 trials) and "BCR-ABL Positive" (2 trials). Many other conditions were trialed in "Unità Operativa Ematologia e Centro Trapianti - Dipartimento di Oncologia ed Ematologia - AUSL Ospedale di Piacenza" in a lesser frequency.

Most popular intervention types in "Unità Operativa Ematologia e Centro Trapianti - Dipartimento di Oncologia ed Ematologia - AUSL Ospedale di Piacenza" are "Drug" (31 trials), "Other" (10 trials), "Genetic" (2 trials), "Procedure" (2 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Nilotinib" (4 trials), "Cyclophosphamide" (2 trials), "Ibrutinib" (2 trials), "Imatinib" (2 trials) and "Lenalidomide" (2 trials). Other intervention names were less common.

The vast majority of trials in "Unità Operativa Ematologia e Centro Trapianti - Dipartimento di Oncologia ed Ematologia - AUSL Ospedale di Piacenza" are 49 trials for "All" genders.

Currently, there are NaN active trials in "Unità Operativa Ematologia e Centro Trapianti - Dipartimento di Oncologia ed Ematologia - AUSL Ospedale di Piacenza". 1 are not yet recruiting, 8 are recruiting, 9 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 24 completed trials in Unità Operativa Ematologia e Centro Trapianti - Dipartimento di Oncologia ed Ematologia - AUSL Ospedale di Piacenza, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Unità Operativa Ematologia e Centro Trapianti - Dipartimento di Oncologia ed Ematologia - AUSL Ospedale di Piacenza, 1 "Phase 1" clinical trials were conducted, 16 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".